December 12, 2013: Eagle Biosciences announces the product launch of a new Anti-Zinc Transporter 8 ELISA. This assay was carefully designed to utilize the ability of ZnT8 Abs to act divalently and to form a bridge between immobilized ZnT8 and ZnT8.
Anti-Zinc Transporter 8 ELISA Assay kit is capable of detecting and quantifying autoantibodies specific to R 325, W 325, or to residue 325 non-specific variants. This assay specificity was designed based on comprehensive human population gene polymorphism research in the field that supports human sera’s reaction to the alleles encoded with these three protein variants. This product further expands Eagle’s Endocrine product line and more specifically, it complements the other circulating autoantibody kits in this line: IAA ELISA Assay Kit, Anti-GAD (Glutamic Acid Decarboxylase) ELISA Assay Kit, and the Anti IA2 ELISA Assay Kit.
“Anti-Zinc Transporter 8, otherwise known as ZnT8 is a novel maker and a new antigenic target for Type 1 Diabetes,” said Dan Keefe, President of Eagle Biosciences. He continued, “We are proud to deliver new, unique solutions like our Anti-Zinc Transporter 8 ELISA that will assist our customers and benefit emerging areas of research. I have no doubt that this kit will be useful in studies surrounding the early detection of Type 1 and Type 2 Diabetes.”
Eagle is offering promotional pricing for researchers measuring insulin (Anti-Zinc Transporter 8, IAA, Anti-GAD, and Anti-IA2) through the next few months. This protein is currently for research use only. Check out the Eagle website www.EagleBio.com or call 866-411-8023 for fulDecember 12, 2013:
Eagle Biosciences announces the product launch of a new Anti-Zinc Transporter 8 ELISA. This assay was carefully designed to utilize the ability of ZnT8 Abs to act divalently and to form a bridge between immobilized ZnT8 and ZnT8.
Anti-Zinc Transporter 8 ELISA Assay kit is capable of detecting and quantifying autoantibodies specific to R 325, W 325, or to residue 325 non-specific variants. This assay specificity was designed based on comprehensive human population gene polymorphism research in the field that supports human sera’s reaction to the alleles encoded with these three protein variants. This product further expands Eagle’s Endocrine product line and more specifically, it complements the other circulating autoantibody kits in this line: IAA ELISA Assay Kit, Anti-GAD (Glutamic Acid Decarboxylase) ELISA Assay Kit, and the Anti IA2 ELISA Assay Kit.
“Anti-Zinc Transporter 8, otherwise known as ZnT8 is a novel maker and a new antigenic target for Type 1 Diabetes,” said Dan Keefe, President of Eagle Biosciences. He continued, “We are proud to deliver new, unique solutions like our Anti-Zinc Transporter 8 ELISA that will assist our customers and benefit emerging areas of research. I have no doubt that this kit will be useful in studies surrounding the early detection of Type 1 and Type 2 Diabetes.”
Eagle is offering promotional pricing for researchers measuring insulin (Anti-Zinc Transporter 8, IAA, Anti-GAD, and Anti-IA2) through the next few months. This protein is currently for research use only. Check out the Eagle website www.EagleBio.com or call 866-411-8023 for full details. l details.